Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 22,727 shares at $17.74 ($405K) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Open-market sale of $405k ALDR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.74 | 18,253 | $324K | 79.9% |
| 2 | $18.24 | 4,474 | $82K | 20.1% |
| Total | $17.84 avg | 22,727 | $405K | 100% |
| Filing → |
| ALDR | SELL | 2016-10-19 | $165K | — | Filing → |
| ALDR | SELL | 2016-06-15 | $171K | — | Filing → |
| ALDR | SELL | 2016-06-01 | $751K | — | Filing → |